Adolescent obesity and puberty: the "perfect storm".
Obesity is the most serious long-term health risk currently facing America's adolescents. Weight gain during adolescence carries a higher risk for adult obesity and the metabolic syndrome. This review highlights early adolescence as a particularly high-risk time for weight gain due to the synergy of naturally occurring metabolic changes along with increasing behavioral risk factors. One of the first potential health effects of abnormal weight gain during this period is earlier puberty, usually manifested as thelarche. The obesity epidemic is clearly implicated in the national trend toward earlier thelarche, although the data are not as strong in relation to menarche. Leptin activation of the hypothalamic-pituitary axis, combined with insulin resistance, and increased adiposity may result in the higher estrogen levels that are linked to breast development. Young adolescents also experience a sharp decline in their level of physical activity, worsening nutritional habits, and other important psychosocial and developmental risk factors that may contribute to obesity and estrogen-dependent disease in later life, including polycystic ovary syndrome and breast cancer. Unfortunately, the very psychosocial factors that contribute to abnormal weight gain during early adolescence make prevention and treatment in this population particularly challenging. Therefore, intervening prior to pubertal onset becomes even more important given the risk factors present once puberty begins.
Jasik
Carolyn Bradner
CB
Department of Pediatrics, School of Medicine, University of California, San Francisco, San Francisco, CA 94143-0503, USA. jasikc@peds.ucsf.edu
Lustig
Robert H
RH
D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000209:etiology; D004967:Estrogens / Q000097:blood; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System; D007333:Insulin Resistance; D020738:Leptin / Q000097:blood; D024821:Metabolic Syndrome / Q000209:etiology; D009765:Obesity / Q000150:complications*; D011085:Polycystic Ovary Syndrome / Q000209:etiology; D011627:Puberty; D012307:Risk Factors; D015430:Weight Gain
D004967:Estrogens; D020738:Leptin